1. Home
  2. MRVI vs PPT Comparison

MRVI vs PPT Comparison

Compare MRVI & PPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRVI
  • PPT
  • Stock Information
  • Founded
  • MRVI 2014
  • PPT 1988
  • Country
  • MRVI United States
  • PPT United States
  • Employees
  • MRVI N/A
  • PPT N/A
  • Industry
  • MRVI Biotechnology: Pharmaceutical Preparations
  • PPT Finance Companies
  • Sector
  • MRVI Health Care
  • PPT Finance
  • Exchange
  • MRVI Nasdaq
  • PPT Nasdaq
  • Market Cap
  • MRVI 371.8M
  • PPT 349.8M
  • IPO Year
  • MRVI 2020
  • PPT N/A
  • Fundamental
  • Price
  • MRVI $2.42
  • PPT $3.70
  • Analyst Decision
  • MRVI Hold
  • PPT
  • Analyst Count
  • MRVI 10
  • PPT 0
  • Target Price
  • MRVI $5.84
  • PPT N/A
  • AVG Volume (30 Days)
  • MRVI 1.4M
  • PPT 156.1K
  • Earning Date
  • MRVI 08-11-2025
  • PPT 01-01-0001
  • Dividend Yield
  • MRVI N/A
  • PPT 8.84%
  • EPS Growth
  • MRVI N/A
  • PPT N/A
  • EPS
  • MRVI N/A
  • PPT N/A
  • Revenue
  • MRVI $219,830,000.00
  • PPT N/A
  • Revenue This Year
  • MRVI N/A
  • PPT N/A
  • Revenue Next Year
  • MRVI $7.23
  • PPT N/A
  • P/E Ratio
  • MRVI N/A
  • PPT N/A
  • Revenue Growth
  • MRVI N/A
  • PPT N/A
  • 52 Week Low
  • MRVI $1.67
  • PPT $3.25
  • 52 Week High
  • MRVI $9.60
  • PPT $3.72
  • Technical
  • Relative Strength Index (RSI)
  • MRVI 49.60
  • PPT 54.54
  • Support Level
  • MRVI $2.28
  • PPT $3.64
  • Resistance Level
  • MRVI $2.47
  • PPT $3.73
  • Average True Range (ATR)
  • MRVI 0.14
  • PPT 0.03
  • MACD
  • MRVI -0.01
  • PPT 0.00
  • Stochastic Oscillator
  • MRVI 27.45
  • PPT 61.11

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

About PPT Putnam Premier Income Trust

Putnam Premier Income Trust is a Massachusetts business trust operating as a non-diversified closed-end management investment company. The fund is currently operating as a diversified fund. Its investment objective is to seek high current income consistent with the preservation of capital by allocating its investments to the U.S. government sector.

Share on Social Networks: